# Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema

> **NCT04089605** · PHASE4 · COMPLETED · sponsor: **Far Eastern Memorial Hospital** · enrollment: 48 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** dexamethasone implant
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT04089605
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-11-01
- **Final completion:** 2019-04-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04089605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04089605, "Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04089605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*